{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:21:56Z","timestamp":1793294516527,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NIDCR","award":["R01 DE019465"],"award-info":[{"award-number":["R01 DE019465"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00784-020-03602-z","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T17:51:03Z","timestamp":1600797063000},"page":"2845-2857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The role of M1 and M2 macrophage polarization in progression of medication-related osteonecrosis of the jaw"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1777-4312","authenticated-orcid":false,"given":"Polytimi","family":"Paschalidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Gkouveris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akrivoula","family":"Soundia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Kalfarentzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Georgaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kostakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boban M.","family":"Erovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Perisanidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos G.","family":"Nikitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"issue":"3","key":"3602_CR1","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/jnci\/djq516","volume":"103","author":"M Pazianas","year":"2011","unstructured":"Pazianas M (2011) Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst 103(3):232\u2013240. https:\/\/doi.org\/10.1093\/jnci\/djq516","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3602_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00784-018-2443-9","volume":"23","author":"N Nonnenmuhlen","year":"2019","unstructured":"Nonnenmuhlen N, Burnic A, Bartella A, Lethaus B, Gerhards F, Ristow O, Pautke C, Holzle F, Steiner T (2019) Comparison of mucosal and mucoperiosteal wound cover for the treatment of medication-related osteonecrosis of the jaw lesions: a retrospective cohort study. Clin Oral Investig 23(1):351\u2013359. https:\/\/doi.org\/10.1007\/s00784-018-2443-9","journal-title":"Clin Oral Investig"},{"issue":"1","key":"3602_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00784-016-1762-y","volume":"21","author":"A Matsumoto","year":"2017","unstructured":"Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss PJ (2017) Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Clin Oral Investig 21(1):127\u2013134. https:\/\/doi.org\/10.1007\/s00784-016-1762-y","journal-title":"Clin Oral Investig"},{"issue":"10","key":"3602_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F, American Association of O, Maxillofacial S (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72(10):1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"3602_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117. https:\/\/doi.org\/10.1016\/s0278-2391(03)00720-1","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"3602_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19(6):733\u2013759. https:\/\/doi.org\/10.1007\/s00198-007-0540-8","journal-title":"Osteoporos Int"},{"key":"3602_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RG Russell","year":"2007","unstructured":"Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH (2007) Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 1117:209\u2013257. https:\/\/doi.org\/10.1196\/annals.1402.089","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"3602_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.oraloncology.2008.04.013","volume":"45","author":"ST Sonis","year":"2009","unstructured":"Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC (2009) Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 45(2):164\u2013172. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.04.013","journal-title":"Oral Oncol"},{"issue":"8","key":"3602_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/jbmr.379","volume":"26","author":"TL Aghaloo","year":"2011","unstructured":"Aghaloo TL, Kang B, Sung EC, Shoff M, Ronconi M, Gotcher JE, Bezouglaia O, Dry SM, Tetradis S (2011) Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 26(8):1871\u20131882. https:\/\/doi.org\/10.1002\/jbmr.379","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3602_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.joms.2018.08.010","volume":"77","author":"D Hadaya","year":"2019","unstructured":"Hadaya D, Soundia A, Gkouveris I, Dry SM, Aghaloo TL, Tetradis S (2019) Development of medication-related osteonecrosis of the jaw after extraction of teeth with experimental periapical disease. J Oral Maxillofac Surg 77(1):71\u201386. https:\/\/doi.org\/10.1016\/j.joms.2018.08.010","journal-title":"J Oral Maxillofac Surg"},{"key":"3602_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","volume":"90","author":"A Soundia","year":"2016","unstructured":"Soundia A, Hadaya D, Esfandi N, de Molon RS, Bezouglaia O, Dry SM, Pirih FQ, Aghaloo T, Tetradis S (2016) Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease. Bone 90:133\u2013141. https:\/\/doi.org\/10.1016\/j.bone.2016.06.011","journal-title":"Bone"},{"issue":"3","key":"3602_CR12","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","volume":"27","author":"A Khan","year":"2016","unstructured":"Khan A, Morrison A, Cheung A, Hashem W, Compston J (2016) Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporos Int 27(3):853\u2013859. https:\/\/doi.org\/10.1007\/s00198-015-3335-3","journal-title":"Osteoporos Int"},{"issue":"11","key":"3602_CR13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567\u20131575. https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"3602_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","volume":"40","author":"S Otto","year":"2012","unstructured":"Otto S, Schreyer C, Hafner S, Mast G, Ehrenfeld M, Sturzenbaum S, Pautke C (2012) Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. J Craniomaxillofac Surg 40(4):303\u2013309. https:\/\/doi.org\/10.1016\/j.jcms.2011.05.003","journal-title":"J Craniomaxillofac Surg"},{"key":"3602_CR15","doi-asserted-by":"publisher","first-page":"471035","DOI":"10.1155\/2014\/471035","volume":"2014","author":"L Rasmusson","year":"2014","unstructured":"Rasmusson L, Abtahi J (2014) Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent 2014:471035\u2013471039. https:\/\/doi.org\/10.1155\/2014\/471035","journal-title":"Int J Dent"},{"key":"3602_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiodt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177\u2013187. https:\/\/doi.org\/10.1016\/j.ctrv.2018.06.007","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3602_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10006-015-0538-x","volume":"20","author":"LF Silva","year":"2016","unstructured":"Silva LF, Curra C, Munerato MS, Deantoni CC, Matsumoto MA, Cardoso CL, Curi MM (2016) Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg 20(1):9\u201317. https:\/\/doi.org\/10.1007\/s10006-015-0538-x","journal-title":"Oral Maxillofac Surg"},{"issue":"11","key":"3602_CR18","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.joms.2012.05.019","volume":"70","author":"F Graziani","year":"2012","unstructured":"Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, Gennai S, Goia F, Miccoli M, Peluso F, Scoletta M, Solazzo L, Colella G (2012) Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg 70(11):2501\u20132507. https:\/\/doi.org\/10.1016\/j.joms.2012.05.019","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"3602_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","volume":"14","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, Taylor PR (2013) Tissue-resident macrophages. Nat Immunol 14(10):986\u2013995. https:\/\/doi.org\/10.1038\/ni.2705","journal-title":"Nat Immunol"},{"key":"3602_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 6:13. https:\/\/doi.org\/10.12703\/P6-13","journal-title":"F1000Prime Rep"},{"key":"3602_CR21","doi-asserted-by":"publisher","unstructured":"Xue Q, Yan Y, Zhang R, Xiong H (2018) Regulation of iNOS on immune cells and its role in diseases. Int J Mol Sci 19(12). https:\/\/doi.org\/10.3390\/ijms19123805","DOI":"10.3390\/ijms19123805"},{"issue":"4","key":"3602_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"M Murakami","year":"2019","unstructured":"Murakami M, Kamimura D, Hirano T (2019) Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity 50(4):812\u2013831. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.027","journal-title":"Immunity"},{"key":"3602_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fimmu.2012.00324","volume":"3","author":"A Ariel","year":"2012","unstructured":"Ariel A, Maridonneau-Parini I, Rovere-Querini P, Levine JS, Muhl H (2012) Macrophages in inflammation and its resolution. Front Immunol 3:324. https:\/\/doi.org\/10.3389\/fimmu.2012.00324","journal-title":"Front Immunol"},{"issue":"1","key":"3602_CR24","doi-asserted-by":"publisher","first-page":"18750","DOI":"10.1038\/s41598-019-55289-2","volume":"9","author":"K Tsuchiya","year":"2019","unstructured":"Tsuchiya K, Suzuki Y, Yoshimura K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T (2019) Macrophage mannose receptor CD206 predicts prognosis in community-acquired pneumonia. Sci Rep 9(1):18750. https:\/\/doi.org\/10.1038\/s41598-019-55289-2","journal-title":"Sci Rep"},{"issue":"6337","key":"3602_CR25","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WKE Ip","year":"2017","unstructured":"Ip WKE, Hoshi N, Shouval DS, Snapper S, Medzhitov R (2017) Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356(6337):513\u2013519. https:\/\/doi.org\/10.1126\/science.aal3535","journal-title":"Science"},{"issue":"6","key":"3602_CR26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jcms.2017.02.023","volume":"45","author":"F Wehrhan","year":"2017","unstructured":"Wehrhan F, Moebius P, Amann K, Ries J, Preidl R, Neukam FW, Weber M (2017) Macrophage and osteoclast polarization in bisphosphonate associated necrosis and osteoradionecrosis. J Craniomaxillofac Surg 45(6):944\u2013953. https:\/\/doi.org\/10.1016\/j.jcms.2017.02.023","journal-title":"J Craniomaxillofac Surg"},{"issue":"2","key":"3602_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00784-014-1273-7","volume":"19","author":"S Hoefert","year":"2015","unstructured":"Hoefert S, Schmitz I, Weichert F, Gaspar M, Eufinger H (2015) Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases. Clin Oral Investig 19(2):497\u2013508. https:\/\/doi.org\/10.1007\/s00784-014-1273-7","journal-title":"Clin Oral Investig"},{"key":"3602_CR28","doi-asserted-by":"publisher","first-page":"31604","DOI":"10.1038\/srep31604","volume":"6","author":"G Russmueller","year":"2016","unstructured":"Russmueller G, Seemann R, Weiss K, Stadler V, Speiss M, Perisanidis C, Fuereder T, Willinger B, Sulzbacher I, Steininger C (2016) The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection. Sci Rep 6:31604. https:\/\/doi.org\/10.1038\/srep31604","journal-title":"Sci Rep"},{"issue":"12 Suppl","key":"3602_CR29","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","volume":"73","author":"SL Ruggiero","year":"2015","unstructured":"Ruggiero SL, Kohn N (2015) Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 73(12 Suppl):S94\u2013S100. https:\/\/doi.org\/10.1016\/j.joms.2015.09.024","journal-title":"J Oral Maxillofac Surg"},{"issue":"9","key":"3602_CR30","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","volume":"46","author":"S Aljohani","year":"2018","unstructured":"Aljohani S, Gaudin R, Weiser J, Troltzsch M, Ehrenfeld M, Kaeppler G, Smeets R, Otto S (2018) Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series. J Craniomaxillofac Surg 46(9):1515\u20131525. https:\/\/doi.org\/10.1016\/j.jcms.2018.05.046","journal-title":"J Craniomaxillofac Surg"},{"issue":"7","key":"3602_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwinski E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster JY, Roux C, Malouf J, Bradley MN, Daizadeh NS, Wang A, Dakin P, Pannacciulli N, Dempster DW, Papapoulos S (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5(7):513\u2013523. https:\/\/doi.org\/10.1016\/S2213-8587(17)30138-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"3602_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cmet.2011.11.013","volume":"15","author":"SK Biswas","year":"2012","unstructured":"Biswas SK, Mantovani A (2012) Orchestration of metabolism by macrophages. Cell Metab 15(4):432\u2013437. https:\/\/doi.org\/10.1016\/j.cmet.2011.11.013","journal-title":"Cell Metab"},{"issue":"7","key":"3602_CR33","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/ATVBAHA.113.300168","volume":"33","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Locati M (2013) Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol 33(7):1478\u20131483. https:\/\/doi.org\/10.1161\/ATVBAHA.113.300168","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5966","key":"3602_CR34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","volume":"327","author":"F Geissmann","year":"2010","unstructured":"Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327(5966):656\u2013661. https:\/\/doi.org\/10.1126\/science.1178331","journal-title":"Science"},{"key":"3602_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"N Wang","year":"2014","unstructured":"Wang N, Liang H, Zen K (2014) Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol 5:614. https:\/\/doi.org\/10.3389\/fimmu.2014.00614","journal-title":"Front Immunol"},{"key":"3602_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2121-8-4","volume":"8","author":"KE Evans","year":"2007","unstructured":"Evans KE, Fox SW (2007) Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol 8:4. https:\/\/doi.org\/10.1186\/1471-2121-8-4","journal-title":"BMC Cell Biol"},{"key":"3602_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-018-0074-9","volume":"38","author":"J Kaneko","year":"2018","unstructured":"Kaneko J, Okinaga T, Hikiji H, Ariyoshi W, Yoshiga D, Habu M, Tominaga K, Nishihara T (2018) Zoledronic acid exacerbates inflammation through M1 macrophage polarization. Inflamm Regen 38:16. https:\/\/doi.org\/10.1186\/s41232-018-0074-9","journal-title":"Inflamm Regen"},{"issue":"12","key":"3602_CR38","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-13-0042","volume":"19","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Atsuta I, Liu S, Chen C, Shi S, Shi S, Le AD (2013) IL-17-mediated M1\/M2 macrophage alteration contributes to pathogenesis of bisphosphonate-related osteonecrosis of the jaws. Clin Cancer Res 19(12):3176\u20133188. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0042","journal-title":"Clin Cancer Res"},{"key":"3602_CR39","doi-asserted-by":"publisher","first-page":"46322","DOI":"10.1038\/srep46322","volume":"7","author":"M Morita","year":"2017","unstructured":"Morita M, Iwasaki R, Sato Y, Kobayashi T, Watanabe R, Oike T, Nakamura S, Keneko Y, Miyamoto K, Ishihara K, Iwakura Y, Ishii K, Matsumoto M, Nakamura M, Kawana H, Nakagawa T, Miyamoto T (2017) Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Sci Rep 7:46322. https:\/\/doi.org\/10.1038\/srep46322","journal-title":"Sci Rep"},{"issue":"6","key":"3602_CR40","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrd.2018.45","volume":"17","author":"C Garbers","year":"2018","unstructured":"Garbers C, Heink S, Korn T, Rose-John S (2018) Interleukin-6: designing specific therapeutics for a complex cytokine. Nat Rev Drug Discov 17(6):395\u2013412. https:\/\/doi.org\/10.1038\/nrd.2018.45","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3602_CR41","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T (2019) Targeting interleukin-6 signaling in clinic. Immunity 50(4):1007\u20131023. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.026","journal-title":"Immunity"},{"issue":"11","key":"3602_CR42","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ni.2109","volume":"12","author":"SJ Galli","year":"2011","unstructured":"Galli SJ, Borregaard N, Wynn TA (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12(11):1035\u20131044. https:\/\/doi.org\/10.1038\/ni.2109","journal-title":"Nat Immunol"},{"issue":"43","key":"3602_CR43","doi-asserted-by":"publisher","first-page":"16572","DOI":"10.1074\/jbc.RA118.003161","volume":"293","author":"Q Yao","year":"2018","unstructured":"Yao Q, Liu J, Zhang Z, Li F, Zhang C, Lai B, Xiao L, Wang N (2018) Peroxisome proliferator-activated receptor gamma (PPARgamma) induces the gene expression of integrin alphaVbeta5 to promote macrophage M2 polarization. J Biol Chem 293(43):16572\u201316582. https:\/\/doi.org\/10.1074\/jbc.RA118.003161","journal-title":"J Biol Chem"},{"key":"3602_CR44","doi-asserted-by":"publisher","unstructured":"Wasnik S, Rundle CH, Baylink DJ, Yazdi MS, Carreon EE, Xu Y, Qin X, Lau KW, Tang X (2018) 1,25-Dihydroxyvitamin D suppresses M1 macrophages and promotes M2 differentiation at bone injury sites. JCI Insight 3(17). https:\/\/doi.org\/10.1172\/jci.insight.98773","DOI":"10.1172\/jci.insight.98773"},{"issue":"19","key":"3602_CR45","first-page":"4464","volume":"21","author":"T Zhang","year":"2017","unstructured":"Zhang T, Shao B, Liu GA (2017) Rosuvastatin promotes the differentiation of peripheral blood monocytes into M2 macrophages in patients with atherosclerosis by activating PPAR-gamma. Eur Rev Med Pharmacol Sci 21(19):4464\u20134471","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"3602_CR46","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1096\/fj.201801791RR","volume":"33","author":"W Zhu","year":"2019","unstructured":"Zhu W, Xu R, Du J, Fu Y, Li S, Zhang P, Liu L, Jiang H (2019) Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw. FASEB J 33(4):5208\u20135219. https:\/\/doi.org\/10.1096\/fj.201801791RR","journal-title":"FASEB J"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-020-03602-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T20:59:46Z","timestamp":1632257986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-020-03602-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3602"],"URL":"https:\/\/doi.org\/10.1007\/s00784-020-03602-z","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the institutional ethics review board (429). The STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}